General discussion, page-257

Most of the CR is for "demonstrable balance sheet strength and inventory investment capacity". So the money might not have to be "spent" until after contracts are granted.

I think people are forgetting that the expected margin for the December quarter was 27-28% and they foretasted lower cash outflows  in certain areas.

I know the current share price might make some investors queasy but the balance sheet, recurring revenue, new customer gains, expectation of 4x-5x growth in bedding chemical sales this year, military in 2 fronts, basically everything apart from the share price is looking very good in my eyes.